Royal Bank of Canada’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-87,212
Closed -$509K 7193
2022
Q4
$509K Buy
87,212
+86,329
+9,777% +$504K ﹤0.01% 3656
2022
Q3
$5K Buy
883
+843
+2,108% +$4.77K ﹤0.01% 6284
2022
Q2
$0 Hold
40
﹤0.01% 7445
2022
Q1
$0 Hold
40
﹤0.01% 7547
2021
Q4
$0 Buy
+40
New ﹤0.01% 7419
2021
Q3
Sell
-2,253
Closed -$10K 7374
2021
Q2
$10K Sell
2,253
-360
-14% -$1.6K ﹤0.01% 6382
2021
Q1
$13K Buy
2,613
+1,072
+70% +$5.33K ﹤0.01% 6198
2020
Q4
$19K Buy
1,541
+1,492
+3,045% +$18.4K ﹤0.01% 5545
2020
Q3
$0 Sell
49
-17
-26% ﹤0.01% 6488
2020
Q2
$1K Sell
66
-66
-50% -$1K ﹤0.01% 6047
2020
Q1
$1K Sell
132
-1,262
-91% -$9.56K ﹤0.01% 6040
2019
Q4
$13K Buy
+1,394
New +$13K ﹤0.01% 5455
2019
Q3
Sell
-20
Closed 6273
2019
Q2
$0 Buy
+20
New ﹤0.01% 6102
2018
Q4
Sell
-262
Closed -$4K 6264
2018
Q3
$4K Sell
262
-7,499
-97% -$114K ﹤0.01% 5754
2018
Q2
$131K Buy
7,761
+39
+0.5% +$658 ﹤0.01% 4088
2018
Q1
$177K Sell
7,722
-2,884
-27% -$66.1K ﹤0.01% 3798
2017
Q4
$274K Buy
10,606
+8,956
+543% +$231K ﹤0.01% 3538
2017
Q3
$24K Buy
1,650
+1,627
+7,074% +$23.7K ﹤0.01% 5117
2017
Q2
$0 Sell
23
-361
-94% ﹤0.01% 6024
2017
Q1
$6K Sell
384
-5,639
-94% -$88.1K ﹤0.01% 5478
2016
Q4
$62K Buy
6,023
+998
+20% +$10.3K ﹤0.01% 4390
2016
Q3
$51K Buy
5,025
+25
+0.5% +$254 ﹤0.01% 4411
2016
Q2
$56K Hold
5,000
﹤0.01% 4384
2016
Q1
$68K Sell
5,000
-100
-2% -$1.36K ﹤0.01% 4291
2015
Q4
$97K Sell
5,100
-1,083
-18% -$20.6K ﹤0.01% 4238
2015
Q3
$116K Sell
6,183
-277
-4% -$5.2K ﹤0.01% 4122
2015
Q2
$95K Buy
6,460
+5,960
+1,192% +$87.6K ﹤0.01% 4381
2015
Q1
$8K Hold
500
﹤0.01% 5183
2014
Q4
$7K Sell
500
-800
-62% -$11.2K ﹤0.01% 5132
2014
Q3
$16K Buy
1,300
+1,000
+333% +$12.3K ﹤0.01% 4796
2014
Q2
$3K Hold
300
﹤0.01% 5161
2014
Q1
$4K Buy
+300
New +$4K ﹤0.01% 5075